1. Home
  2. CRWS vs SKYE Comparison

CRWS vs SKYE Comparison

Compare CRWS & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.78

Market Cap

29.6M

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.84

Market Cap

24.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
SKYE
Founded
1957
2012
Country
United States
United States
Employees
168
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
24.2M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
CRWS
SKYE
Price
$2.78
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
31.0K
199.5K
Earning Date
02-11-2026
05-08-2026
Dividend Yield
11.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.51
N/A
52 Week Low
$2.35
$0.57
52 Week High
$3.38
$5.75

Technical Indicators

Market Signals
Indicator
CRWS
SKYE
Relative Strength Index (RSI) 51.38 52.64
Support Level $2.49 $0.71
Resistance Level $2.94 $1.14
Average True Range (ATR) 0.09 0.09
MACD 0.00 -0.01
Stochastic Oscillator 44.44 29.19

Price Performance

Historical Comparison
CRWS
SKYE

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: